News Coverage 11.06.19 Share on Twitter Share on Facebook Share on LinkedIn Early Results from First-In-U.S. Trial of CRISPR-Edited Immune Cells for Cancer Patients Suggest Safety of Approach Related Announcement, Press Release PICI Invests $1 Million+ in 5 Early Career Researchers Announcement, Patient Story Living Proof: Cancer Vaccine Recipients Bring Their Sto Research Update Cancer Vaccines: A New Era in Cancer Treatment